Pyrrolidine dithiocarbamate, a inhibitor of NF- κB, enhances chemosensitivity of ovarian cancer cells to cisplatin

Guo-hong LIU,Bo WANG

DOI: https://doi.org/10.3872/j.issn.1007-385X.2008.04.012

2008-01-01

Abstract:Objective: To determine the promoting effect of pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-κB, on the sensitivity of human ovarian cancer cell line SKOV-3 to chemoagent cisplatin and the possible mechanisms. Methods: SKOV-3 cells were treated with various concentrations of cisplatin and PDTC combination for different periods. Then the growth inhibition of SKOV-3 cells were observed by MTT assay, expression of I-κBα and P65 protein by Western blotting assay, and apoptosis of cells by flow cytometry. Results: Separate application of both cisplatin (0.1-10 μg/ml) and PDTC (10-40 μmol/L L) significantly inhibited the growth of SKOV-3 cells and caused cell apoptosis(P < 0.05 or P < 0.01). Even at lower concentration, cisplatin(0.01 μg/ml) combined with PDTC (2.5, 5 μmol/L) resulted more significant growth inhibition and apoptosis of SKOV-3 cells than cisplatin alone (both P < 0.05). Cisplatin alone reduced cytoplasmic I-κBα protein in the cytoplasm and increased nuclear P65 protein compared with control group (both P < 0.05), which could be reversed by addition of PDTC. Conclusion: Low dose of PDTC can enhance the chemosensitivity of ovarian cancer cells to cisplatin, which might be related to PDTC-induced I-κBα protein and the subsequent inhibition of nuclear translocation of P65 protein.